SPONSOR
FengYan Jin
Total Trials
1
Recruiting
1
Phases
N/A
FengYan Jin is a clinical research sponsor with 1 registered studies on ClinicalTrials.gov, of which 1 are actively recruiting participants. Research covers conditions including Multiple Myeloma, First Relapse.
Studies span multiple clinical phases, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — FengYan Jin
How many clinical trials has FengYan Jin sponsored?
ClinicalMetric currently tracks 1 clinical trials sponsored by FengYan Jin, of which 1 are actively recruiting participants. These trials cover conditions including Multiple Myeloma, First Relapse. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does FengYan Jin research focus on?
FengYan Jin clinical trials span Multiple Myeloma, First Relapse. Sponsor focus areas evolve as trials complete and new programs launch.
How do I participate in a FengYan Jin clinical trial?
To participate in a FengYan Jin trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all FengYan Jin trials with current recruitment status updated daily.
Clinical Trials by FengYan Jin
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology